The British pharma and consumer products maker had announced the open offer in November last year to raise its stake in its subsidiary to 75 per cent from 43.16 per cent at present.
.jpg)
But no general trade, because that is a completely different channel of distribution.
Taking control of manufacturing will help boost profits for the food business, but it could leave the group saddled with huge debt.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances